account_balance
Investment manager · 13F filer · SEC CIK 1230765
Rice Hall James & Associates, LLC
Reported value$2.05Bas of Jun 30, 2026
Positions240 14 new, 17 sold out
Top 10 weight24.1%LGND alone is 4%
FiledAug 738 days after quarter end
Portfolio · as of Jun 30, 2026
Where the money is
New or addedTrimmedHeld
LGNDLigand Pharmaceuticals Inc
4.2%Trimmed −5%
ACIWAci Worldwide Inc
2.5%
ARLOArlo Technologies Inc
2.4%
FNFabrinet
2.4%Trimmed −17%
ESTAEstablishment Labs Hldgs Inc
2.3%Added +2%
XPOXpo Inc
2.2%
ZDZiff Davis Inc
2.1%Added +3%
FOURShift4 PMTS Inc
2.1%Added +3%
KNSAKiniksa Pharmaceuticals Intl
1.9%Added +3%
ASNDAscendis Pharma A/s
1.9%New
LRNStride Inc
1.8%
PBHPrestige Consmr Healthcare I
1.6%Added +32%
LGNDLigand Pharmaceuticals Inc
4.2%Trimmed −5%
ACIW2.5%ARLO2.4%FNFabrinet
2.4%Trimmed −17%
ESTAEstablishment Labs Hldgs Inc
2.3%Added +2%
XPOXpo Inc
2.2%
ZD2.1%FOUR2.1%KNSA1.9%ASND1.9%LRN1.8%PBH1.6%Boxes show the top 12 stocks, sized against each other. The bar above shows how much of the fund they are. 13F only covers US-listed stocks, so foreign holdings and short positions are missing.
Show the top 12 as a list
LGND Ligand Pharmaceuticals Inc 4.2% Trimmed −5%ACIW Aci Worldwide Inc 2.5% HeldARLO Arlo Technologies Inc 2.4% HeldFN Fabrinet 2.4% Trimmed −17%ESTA Establishment Labs Hldgs Inc 2.3% Added +2%XPO Xpo Inc 2.2% HeldZD Ziff Davis Inc 2.1% Added +3%FOUR Shift4 PMTS Inc 2.1% Added +3%KNSA Kiniksa Pharmaceuticals Intl 1.9% Added +3%ASND Ascendis Pharma A/s 1.9% NewLRN Stride Inc 1.8% HeldPBH Prestige Consmr Healthcare I 1.6% Added +32%
What changed